Advertisement

The Latest

Lawrence, Kan.-based LMH Health has expanded use of a collaborative care model across its primary care clinics to address growing mental health needs. The evidence-based approach integrates behavioral health services into primary care, allowing patients with moderate depression or anxiety…

Several major U.S. health systems are backing Vista AI’s effort to automate MRI scanning as hospitals grapple with workforce shortages and rising imaging demand. Vista AI, based in Palo Alto, Calif., said in a Jan. 14 news release that it…

For decades, academic health systems have approached innovation cautiously; not for lack of ambition, but because the economics rarely worked in their favor. Thin operating margins, long development timelines and uncertain returns made large-scale investment in innovation difficult to justify,…

In this episode, Kathy Kohnke of Ingenovis Health and Jodi Pahl and Vince Dindia of Bon Secours Mercy Health discuss rising patient acuity, clinician burnout, and the need for flexible, data driven workforce models. They share lessons on collaboration, internal…

Columbus City Schools held a ribbon-cutting ceremony Jan. 13 to mark the return of its pharmacy technician program at Fort Hayes Career Center, relaunching the lab with support from industry partners and updated funding. The program prepares 25 students each…

Sacramento, Calif.-based UC Davis Health has installed the region’s first photon-counting CT scanner, a next-generation imaging system that produces sharper images at lower radiation doses. The Siemens-manufactured scanner, deployed at the health system’s 48X Complex in Sacramento, captures ultra-high-resolution images…

Google is expanding its open medical AI offerings with an updated model designed to better interpret complex medical images and a new tool focused on converting medical speech into text. The company on Jan. 13 released MedGemma 1.5, an updated…

The FDA is requesting that drugmakers remove suicidal ideation and behavior warnings from the labeling of three GLP-1 receptor agonists — Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound (tirzepatide) — effective Jan. 13, 2026. The FDA’s decision follows a meta-analysis of…

Advertisement